Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid Tumors
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2021-12-17
- Lead Sponsor
- MetaboMed Inc
- Target Recruit Count
- 30
- Registration Number
- NCT04990739
- Locations
- 🇺🇸
Tennessee Oncology, Nashville, Tennessee, United States
🇮🇱Rambam MC, Haifa, Israel
🇮🇱Sourasky MC, Tel Aviv, Israel
News
No news found